Cigna Group
XMUN:CGN
Cigna Group
Non-Reccuring Items
Cigna Group
Non-Reccuring Items Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Non-Reccuring Items | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
C
|
Cigna Group
XMUN:CGN
|
Non-Reccuring Items
-$1B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-25%
|
|
|
Quest Diagnostics Inc
NYSE:DGX
|
Non-Reccuring Items
-$44m
|
CAGR 3-Years
22%
|
CAGR 5-Years
-17%
|
CAGR 10-Years
N/A
|
|
|
CVS Health Corp
NYSE:CVS
|
Non-Reccuring Items
-$5.4B
|
CAGR 3-Years
14%
|
CAGR 5-Years
-29%
|
CAGR 10-Years
N/A
|
|
|
Cigna Corp
NYSE:CI
|
Non-Reccuring Items
-$1B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-25%
|
|
|
Laboratory Corporation of America Holdings
NYSE:LH
|
Non-Reccuring Items
-$131.5m
|
CAGR 3-Years
25%
|
CAGR 5-Years
23%
|
CAGR 10-Years
-1%
|
|
|
Guardant Health Inc
NASDAQ:GH
|
Non-Reccuring Items
-$4.9m
|
CAGR 3-Years
3%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Cigna Group
Glance View
Cigna Group, a recognized titan in the health services landscape, traces its origins to 1792 when it began as the Insurance Company of North America (INA). This rich history speaks volumes about its deep-rooted expertise and robust resilience in an ever-evolving industry. Today, Cigna operates as a global health services powerhouse, deriving its core revenues from an intricate blend of health insurance products and services targeted towards employers, individuals, and government entities. The company's ability to seamlessly fuse traditional insurance models with innovative health solutions highlights its commitment to improving patient outcomes. Cigna's operational model is anchored on its extensive provider network, supplemented by a suite of digital health tools aimed at enhancing customer engagement. This hybrid approach not only simplifies access to medical care but also reinforces its strategic focus on affordability and personalized health journeys for its clients. Financially, Cigna's success is a byproduct of its diversified revenue streams, encompassing global health care, international markets, and supplemental health benefits. At its core, Cigna makes money through premium collections, investment income, and administrative fees from managing prescription drug plans and health services. With the acquisition of Express Scripts in 2018, Cigna prominently positioned itself in the pharmacy benefits management sector, adding another lucrative revenue channel. This strategic maneuver has fostered vertical integration within the company, aligning its pharmacy services with its insurance offerings to manage costs more effectively. Through a relentless pursuit of operational efficiency and strategic expansion, Cigna continues to leverage its scale and diversified offerings, remaining a key player in delivering accessible and cost-effective health care solutions worldwide.
See Also
What is Cigna Group's Non-Reccuring Items?
Non-Reccuring Items
-1B
USD
Based on the financial report for Dec 31, 2025, Cigna Group's Non-Reccuring Items amounts to -1B USD.
What is Cigna Group's Non-Reccuring Items growth rate?
Non-Reccuring Items CAGR 10Y
-25%
Over the last year, the Non-Reccuring Items growth was -142%.